[Churg-Strauss syndrome in an asthmatic man treated with montelukast: continued controversy].
Pérez de Llano
L A
LA
Veres Racamonde
A
A
Parra Arrondo
A
A
D000085:Acetates / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology*; D015267:Churg-Strauss Syndrome / Q000139:chemically induced* / Q000150:complications* / Q000175:diagnosis; D003521:Cyclopropanes; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013440:Sulfides; D013997:Time Factors
D000085:Acetates; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast